BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1541010)

  • 1. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance.
    Beck O; Lafolie P; Hjemdahl P; Borg S; Odelius G; Wirbing P
    Clin Chem; 1992 Feb; 38(2):271-5. PubMed ID: 1541010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood.
    Huang W; Moody DE
    J Anal Toxicol; 1995 Oct; 19(6):333-42. PubMed ID: 8926726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.
    Beck O; Lin Z; Brodin K; Borg S; Hjemdahl P
    J Anal Toxicol; 1997; 21(7):554-7. PubMed ID: 9399125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
    Fraser AD; Meatherall R
    J Anal Toxicol; 1996; 20(4):217-23. PubMed ID: 8835658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required.
    Meatherall R
    J Anal Toxicol; 1994; 18(7):385-90. PubMed ID: 7861751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological screening of benzodiazepines in urine: improved detection of oxazepam intake.
    Beck O; Lafolie P; Odelius G; Boreus LO
    Toxicol Lett; 1990 Jun; 52(1):7-14. PubMed ID: 2192483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary screening for alprazolam, triazolam, and their metabolites with the EMIT d.a.u. benzodiazepine metabolite assay.
    Fraser AD
    J Anal Toxicol; 1987; 11(6):263-6. PubMed ID: 3323671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives.
    Jones CE; Wians FH; Martinez LA; Merritt GJ
    Clin Chem; 1989 Jul; 35(7):1394-8. PubMed ID: 2667799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoassay detection of nordiazepam, triazolam, lorazepam, and alprazolam in blood.
    Huang W; Moody DE; Andrenyak DM; Rollins DE
    J Anal Toxicol; 1993 Oct; 17(6):365-9. PubMed ID: 7903726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary screening for adinazolam and its major metabolites by the Emit d.a.u. and FPIA benzodiazepine assays with confirmation by HPLC.
    Fraser AD; Isner AF; Bryan W
    J Anal Toxicol; 1993; 17(7):427-31. PubMed ID: 8309217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of four immunoassays for the detection of lorazepam in urine.
    Meatherall R; Fraser AD
    Ther Drug Monit; 1998 Dec; 20(6):673-5. PubMed ID: 9853986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
    Valentine JL; Middleton R; Sparks C
    J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary screening for alpha-OH triazolam by FPIA and EIA with confirmation by GC/MS.
    Fraser AD; Bryan W; Isner AF
    J Anal Toxicol; 1992; 16(6):347-50. PubMed ID: 1293398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedure for verification of flunitrazepam and nitrazepam intake by gas chromatographic-mass spectrometric analysis of urine.
    Lin Z; Beck O
    J Pharm Biomed Anal; 1995 Apr; 13(4-5):719-22. PubMed ID: 9696596
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved cross-reactivity to alpha OH triazolam in the BMC CEDIA DAU urine benzodiazepine assay.
    Fraser AD; Meatherall R
    Ther Drug Monit; 1998 Jun; 20(3):331-4. PubMed ID: 9631932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cross-reactivity of Instant-View M-1 for detection of benzodiazepine-related drugs and their metabolites in urine].
    Torikoshi A; Namera A; Arima Y; Toubou H; Tajima T; Shiraishi H; Nagao M
    Chudoku Kenkyu; 2014 Mar; 27(1):33-8. PubMed ID: 24724359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine misuse by drug addicts.
    Garretty DJ; Wolff K; Hay AW; Raistrick D
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():68-73. PubMed ID: 9022890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of parent benzodiazepines by gas chromotography/mass spectroscopy (GC/MS) from urinary extracts treated with B-glucuronidase.
    Needleman SB; Porvaznik M
    Forensic Sci Int; 1995 May; 73(1):49-60. PubMed ID: 7750882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEDIA dau Benzodiazepine screening assay: a reformulation.
    Meatherall RC; Fraser AD
    J Anal Toxicol; 1998; 22(4):270-3. PubMed ID: 9681328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Emit tox benzodiazepine and barbiturate assays on the Vitalab Viva analyser and FPIA on the Abbott ADx analyser.
    Charlier CJ; Plomteux GJ
    Clin Chem Lab Med; 2000 Jul; 38(7):615-8. PubMed ID: 11028766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.